cdk4/6 for hr early breast cancer: monarche results
Published 2 months ago • 81 plays • Length 3:24Download video MP4
Download video MP3
Similar videos
-
1:09:24
raising the bar in hr /her2- early breast cancer: cdk4 and 6 inhibitors
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
6:36
adjuvant cdk4/6 inhibition in early-stage hr-positive breast cancer | ruth o'regan
-
5:07
what is the role of cdk4/6 inhibitors in early breast cancer?
-
2:22
cdk4/6 inhibitors in early stage hr /her2- disease
-
7:58
cdk 4/6 inhibitors: how are they used in metastatic breast cancer treatment?
-
1:12
monarche: adjuvant abemaciclib in hr breast cancer
-
1:51
reflecting on the use of cdk4/6 inhibitors in hr breast cancer
-
29:09
interactive case: choosing and using cdk4/6 inhibitors in breast cancer - first-line therapy
-
9:18
clinical experience: cdk4/6 inhibitors in breast cancer
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
0:37
cdk4/6 inhibitors in her2-negative breast cancer based on phase iii monaleesa-7 trial
-
58:22
adjuvant cdk4 and 6 inhibition to prevent recurrences in high-risk hr /her2- early breast cancer
-
7:09
abemaciclib for hr-positive metastatic breast cancer
-
7:40
cdk4/6 inhibitors in the first-line treatment setting
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
7:59
what are cdk 4/6 inhibitors for breast cancer?
-
5:16
cdk4/6 inhibitor abemaciclib plus fulvestrant improves overall survival in hr-positive/her2-nega...
-
26:40
cdk 4/6 inhibition in early breast cancer by dr. ahmed saadeddin 18-6-2021 (day1)